Pretreatment hemoglobin (Hgb) is associated with response to neoadjuvant chemoradiation therapy (CRT) in patients with oral cavity and oropharynx cancers (OC&OP SCC)
C. Glaser, G.V. Kornek, T. Leitha, S. Lang, W. Millesi, F. Wanschitz, R.S. LaveyVolume:
35
Year:
1999
Language:
english
DOI:
10.1016/s0959-8049(99)81043-0
File:
PDF, 152 KB
english, 1999